Sympathetic Ophthalmia - An Overview
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2022/05/17
-
Indian UGC (journal)
-
Refrences128
-
Citations3
-
Mamta Agarwal Medical Research Foundation, Sankara Nethralaya, Uveitis & Cornea Services, Chennai, India ORCID (unauthenticated)
-
Aleksandra Radosavljevic Faculty of Medicine, University of Belgrade, Belgrade, Serbia ORCID (unauthenticated)
-
Mudit Tyagi L V Prasad Eye Institute, Hyderabad, India
-
Francesco Pichi Eye Institute, Cleveland Clinic, Abu Dhabi, UAECleveland Clinic Lerner College of Medicine, Case Western Reserve University Cleveland, Cleveland, Ohio, USA
-
Aisha A. Al Dhanhani Eye Institute, Cleveland Clinic, Abu Dhabi, UAE
-
Aditi Agarwal Medical Research Foundation, Sankara Nethralaya, Chennai, India
-
Emmett T. Cunningham The Department of Ophthalmology, California Pacific Medical Center, San Francisco, California, USAWest Coast Retina Medical Group, San Francisco, California, USAThe Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USAProctor Foundation, UCSF School of MedicineThe Francis I., San Francisco, California, USA
Cite
Agarwal, Mamta, et al. “Sympathetic Ophthalmia - An Overview”. Ocular Immunology and Inflammation, vol. 31, no. 4, 2022, pp. 793-09, https://doi.org/10.1080/09273948.2022.2058554.
Agarwal, M., Radosavljevic, A., Tyagi, M., Pichi, F., Al Dhanhani, A. A., Agarwal, A., & Cunningham, E. T. (2022). Sympathetic Ophthalmia - An Overview. Ocular Immunology and Inflammation, 31(4), 793-809. https://doi.org/10.1080/09273948.2022.2058554
Agarwal, Mamta, Aleksandra Radosavljevic, Mudit Tyagi, Francesco Pichi, Aisha A. Al Dhanhani, Aditi Agarwal, and Emmett T. Cunningham. “Sympathetic Ophthalmia - An Overview”. Ocular Immunology and Inflammation 31, no. 4 (2022): 793-809. https://doi.org/10.1080/09273948.2022.2058554.
Agarwal M, Radosavljevic A, Tyagi M, Pichi F, Al Dhanhani AA, Agarwal A, et al. Sympathetic Ophthalmia - An Overview. Ocular Immunology and Inflammation. 2022;31(4):793-809.
Journal Categories
Medicine
Medicine (General)
Medicine
Ophthalmology
You May Also Like
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- Evolution of geographic atrophy of the retinal pigment epithelium
- Pachychoroid disease
- Eye health risks associated with the use of electronic devices and awareness of youth
- The influence of high addition soft multifocal contact lenses on visual performance
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Retina | 2001 | |||
| Retina | International Journal of Clinical and Experimental Medicine |
| 2015 | |
| Retina | 1999 | |||
| Retina | 1993 | |||
| Retina | 1984 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| An Eye for an Eye?: Problematic Risk–Benefit Trade-Offs in Whole Eye Transplantation | The American Journal of Bioethics |
| 2024 | |
| Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging | Ocular Immunology and Inflammation |
| 2023 | |
Regulatory Role, Mechanism, and Metabolic Profile of BIOTIN in
Gene Expression | Current Pharmacogenomics and Personalized Medicine |
| 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 1
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging and was published in 2023. The most recent citation comes from a 2024 study titled An Eye for an Eye?: Problematic Risk–Benefit Trade-Offs in Whole Eye Transplantation. This article reached its peak citation in 2023, with 2 citations. It has been cited in 3 different journals. Among related journals, the The American Journal of Bioethics cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.